Bacteriophages were independently discovered by Frederick Twort in 1915 and Félix d’Hérelle in 1917. Twort observed the formation of transparent areas in bacterial colonies and suggested that this might be due to the presence of a virus. In 1917, d’Hérelle published his findings while studying bacterial dysentery and introduced the term bacteriophage. He continued his research on these viruses and is often regarded as the father of bacteriophage research.
The term bacteriophage is derived from the word bacteria and the Greek word phagein, which means to eat. The name refers to the destruction of bacterial cells and not to the actual consumption of bacteria. Bacteriophages, also known as phages, are naturally occurring viruses and are not man-made.
What is Bacteriophage?
A bacteriophage or phage is a virus that infects bacteria and can replicate only inside a susceptible bacterial host cell. Bacteriophages are acellular. They do not have ribosomes like bacterial cells. The cellular machinery of the host cell is used for the synthesis of viral proteins and the formation of new phage particles. Bacteriophages are obligate intracellular parasites.
Bacteriophages are host-specific. Some phages infect only certain strains of a bacterial species, while others can infect bacteria of different species. The host cells of bacteriophages are bacterial cells and not eukaryotic cells such as plant, animal or fungal cells.
Not all bacteriophages kill the bacterial cell immediately after infection. The genome of a temperate phage may remain within the bacterial cell as a prophage. In some filamentous phages, new phage particles are produced and released without lysis of the bacterial cell.
Pronunciation: Bacteriophage (bak-TEER-ee-uh-fayj) and phage (fayj).
Characteristics of Bacteriophage
The important characteristics of bacteriophages are as follows:
- Bacteriophages are microscopic viral particles. Their dimensions are generally measured in nanometres.
- They may be of different shapes such as polyhedral, spherical, filamentous, etc. Some have a complex structure with a tail.
- Some filamentous phages measure about 6–8 nm in diameter and 800–2000 nm in length.
- They do not have an independent metabolic system.
- Ribosomes are absent in bacteriophages. The synthesis of phage proteins takes place with the help of bacterial ribosomes.
- The enzymes, energy and other cellular components of the bacterial cell are utilized during phage multiplication.
- In phage biology, the range of bacteria that a bacteriophage can infect is known as its host range. It may be narrow or broad depending upon the bacteriophage.
- Mutations and genetic recombination give rise to genetic variation in bacteriophages. They can evolve and adapt to different bacterial hosts.
- The infective phage particles present outside the bacterial cell are called virions. These are metabolically inactive.
- Bacteriophages lack cellular organization and are generally considered non-living. They cannot reproduce independently but can replicate within the bacterial cell and undergo evolution. Whether viruses are living or non-living is still debated among scientists.
Structure of Bacteriophage
The morphology of bacteriophages varies from one type of phage to another. T4 bacteriophage has a complex structure consisting of an elongated head and a contractile tail. The head, tail, baseplate and the leg-like tail fibres give the T4 bacteriophage a robot-like appearance.
In some bacteriophages, the tail is absent. The tail of a bacteriophage may be contractile or non-contractile. The baseplate and tail fibres are not present in all bacteriophages.
The different parts of T4 bacteriophage and their functions are mentioned below.

Head or Capsid
- The head of T4 bacteriophage is elongated and icosahedral in shape. It measures about 120 nm in length and 86 nm in width.
- The protein covering of the head is called the capsid, which is mainly composed of gp23 and gp24 proteins.
- Double-stranded DNA (dsDNA) is present within the head. The capsid protects the DNA from physical damage and the action of nucleases.
- One of the vertices of the capsid contains a portal made up of gp20 protein. The entry and exit of DNA from the head take place through this portal.
Neck and Collar
- The neck is a short structure that joins the head to the tail of the bacteriophage.
- The collar and whiskers are made up of a protein called fibritin. Six fibritin units form the collar around the neck and another six form the whiskers.
- These are involved in the attachment of long tail fibres and regulation of their position.
- Under unfavourable environmental conditions, the long tail fibres remain in a retracted position.
Tail Tube
- The tail tube is a hollow cylindrical structure composed of gp19 protein.
- It extends from the neck to the baseplate and is enclosed within the contractile tail sheath.
- During infection, the phage DNA passes through this tube into the bacterial cell.
- The tail tube is non-contractile.
Contractile Tail Sheath
- The tail sheath consists of 138 subunits of gp18 protein arranged in 23 rings around the tail tube.
- The upper end of the sheath is attached to the neck and the lower end to the baseplate.
- The tail sheath becomes shorter and wider during contraction. This helps in the penetration of the bacterial cell envelope by the tail apparatus.
Baseplate
- The baseplate is a hexagonal protein structure located at the lower end of the tail.
- Both long and short tail fibres are attached to the baseplate.
- At the centre of the baseplate, there is a cell-puncturing structure made up of gp5, gp27 and gp5.4 proteins. The gp5 protein exhibits lysozyme activity and helps in the breakdown of peptidoglycan present in the bacterial cell wall.
- During attachment to the bacterial cell, the baseplate changes from a dome-shaped structure to a star-shaped structure, resulting in the contraction of the tail sheath.
Tail Fibres and Tail Pins
- T4 bacteriophage has six long tail fibres and six short tail fibres.
- The long tail fibres are attached to the peripheral region of the baseplate. Each fibre has a bend in its middle region.
- The receptor-binding regions are present at the tips of the long tail fibres. These help in the recognition of specific receptors on the surface of the bacterial cell.
- The short tail fibres, also referred to as tail pins, are composed of gp12 protein.
- Before attachment to the bacterial cell, the short tail fibres remain folded beneath the baseplate. During infection, they unfold and bind irreversibly to the bacterial surface.
Genetic Material of Bacteriophage

- Bacteriophages contain either DNA or RNA as their genetic material, which may be single-stranded or double-stranded. Double-stranded DNA (dsDNA) is found in most of the known bacteriophages.
- The genome of a bacteriophage may be linear or circular. In some bacteriophages, the genome is divided into several segments.
- T4 bacteriophage has a linear double-stranded DNA genome of 168,903 base pairs (bp).
- The DNA of M13 bacteriophage is circular and single-stranded (ssDNA). It consists of 6,407 nucleotides.
- MS2 bacteriophage contains a linear, positive-sense single-stranded RNA (ssRNA) of 3,569 nucleotides.
- In phi6 (φ6) bacteriophage, the genome consists of three segments of double-stranded RNA (dsRNA), known as small (S), medium (M) and large (L) segments. The total size of the genome is about 13.4 kb.
- The size of the bacteriophage genome varies from a few thousand to several hundred thousand nucleotides or base pairs.
- The genes present in the phage genome code for structural proteins and proteins involved in the replication of nucleic acids.
- T4 bacteriophage DNA contains genes coding for enzymes such as DNA polymerase, helicase and DNA ligase, which are involved in DNA replication.
- Some of the proteins coded by phage genes are involved in the recognition of receptors present on the bacterial surface, regulation of cellular activities of the host and protection of the phage against bacterial defence mechanisms.
- In some temperate bacteriophages, there are genes responsible for the integration of phage DNA into the bacterial chromosome and maintenance of the prophage.
Classification of Bacteriophage
Bacteriophages are classified on the basis of their morphology, genetic material, mode of infection and evolutionary relationships. In modern virus taxonomy, bacteriophages are mainly classified on the basis of their genomic characteristics and evolutionary relationships.
A. Classification Based on Morphology

Depending upon the shape and structure of the virion, bacteriophages can be of the following types:
- Tailed bacteriophages– These have an icosahedral or elongated icosahedral head attached to a tail. Based on the morphology of the tail, they can be of three types:
- Myovirus morphotype– They possess a long contractile tail. Eg., T4 bacteriophage.
- Siphovirus morphotype– The tail is long and non-contractile. Eg., lambda (λ) bacteriophage.
- Podovirus morphotype– They have a short non-contractile tail. Eg., T7 bacteriophage.
- Filamentous bacteriophages– These are elongated, thread-like phages in which a distinct head and tail are absent. Eg., M13 and fd bacteriophages.
- Polyhedral non-tailed bacteriophages– They have an icosahedral capsid without a tail. Eg., φX174 and MS2.
- Pleomorphic bacteriophages– These do not have a definite shape. Acholeplasma phage L2 possesses a lipid-containing envelope but lacks a regular capsid structure.
- Enveloped non-tailed bacteriophages– In some non-tailed bacteriophages, the icosahedral nucleocapsid is surrounded by a spherical lipid envelope. Eg., φ6 bacteriophage.
B. Classification Based on Genetic Material
On the basis of their genetic material, bacteriophages are divided into four groups:
- Double-stranded DNA (dsDNA) phages– These contain double-stranded DNA as their genetic material. Eg., T4, T7 and lambda bacteriophages.
- Single-stranded DNA (ssDNA) phages– Single-stranded DNA is found in bacteriophages such as M13, fd and φX174.
- Double-stranded RNA (dsRNA) phages– They contain double-stranded RNA as their genetic material. In φ6 bacteriophage, the RNA is present in three segments.
- Single-stranded RNA (ssRNA) phages– The genetic material of bacteriophages such as MS2 and Qβ is positive-sense single-stranded RNA.
The size and organization of these genomes are described in the preceding section on the genetic material of bacteriophages.
C. Classification Based on Infection Strategy
Based on the mode of infection, bacteriophages can be of the following types:
- Virulent bacteriophages– These phages reproduce by the lytic cycle and do not establish lysogeny. The new phage particles are released by lysis of the bacterial cell. Eg., T4 and T7 bacteriophages.
- Temperate bacteriophages– They can undergo both lytic and lysogenic cycles. In the lysogenic cycle, the phage genome remains within the bacterial cell as a prophage, either integrated into the bacterial chromosome or as an extrachromosomal genetic element. Eg., lambda and P1 bacteriophages.
- Chronic productive bacteriophages– The production and release of new phage particles take place without lysis of the bacterial cell. This type of infection is found in filamentous bacteriophages such as M13. Some filamentous bacteriophages can also exist as prophages.
Virulent, temperate and chronic productive phages are descriptive groups based on their mode of infection and not formal taxonomic groups.
Modern ICTV Classification
- The formal taxonomic classification of bacteriophages is given by the International Committee on Taxonomy of Viruses (ICTV).
- The modern classification of bacteriophages is based on similarities in their nucleotide sequences, genome organization, encoded proteins and evolutionary relationships.
- Previously, tailed bacteriophages belonging to the order Caudovirales were divided into three families on the basis of their tail morphology. These were Myoviridae, Siphoviridae and Podoviridae.
- The order Caudovirales and these three families were abolished in the ICTV taxonomic changes ratified in 2022.
- Tailed double-stranded DNA viruses infecting bacteria and archaea belong to the class Caudoviricetes. This class is placed under the phylum Uroviricota of the realm Duplodnaviria.
- Pantevenvirales, Autographivirales and Crassvirales are some of the orders belonging to the class Caudoviricetes.
- T4 bacteriophage belongs to the family Straboviridae, T7 to Autotranscriptaviridae and lambda bacteriophage to Zimmerviridae.
- M13, a filamentous bacteriophage, belongs to the family Inoviridae.
- The RNA-containing bacteriophages MS2 and φ6 belong to the families Fiersviridae and Cystoviridae, respectively.
- The terms myovirus, siphovirus and podovirus are still used to describe the morphology of tailed bacteriophages but do not represent formal taxonomic families.
The classification of some commonly studied bacteriophages is given below:
| Bacteriophage | Morphology | Genetic Material | Mode of Infection | Taxonomic Family |
|---|---|---|---|---|
| T4 | Long contractile tail | dsDNA | Virulent | Straboviridae |
| T7 | Short non-contractile tail | dsDNA | Virulent | Autotranscriptaviridae |
| Lambda (λ) | Long non-contractile tail | dsDNA | Temperate | Zimmerviridae |
| M13 | Filamentous | ssDNA | Chronic productive infection | Inoviridae |
| φX174 | Icosahedral, non-tailed | ssDNA | Virulent | Eubullaviridae |
| MS2 | Icosahedral, non-tailed | ssRNA | Virulent | Fiersviridae |
| φ6 | Enveloped, non-tailed | dsRNA | Virulent | Cystoviridae |
| L2 | Enveloped, pleomorphic | dsDNA | Temperate, non-lytic productive infection | Plasmaviridae |
Life Cycle of Bacteriophage
The reproduction of bacteriophages takes place within susceptible bacterial cells. The phage genome enters the bacterial cell and utilizes the cellular machinery of the host for the synthesis of viral nucleic acids and proteins.
In some bacteriophages, the newly formed phage particles are released by lysis of the bacterial cell, whereas in others, the phage genome may remain within the bacterial cell for several generations. Some phages are also capable of producing and releasing new phage particles without causing lysis of the host cell.
Lytic Cycle
The lytic cycle is a type of bacteriophage replication in which new phage particles are produced within the bacterial cell and released by lysis of the host cell. T4 and T7 bacteriophages reproduce by the lytic cycle.
The lytic cycle involves the following steps:

- Adsorption- The bacteriophage binds to specific receptors present on the surface of the bacterial cell. In T4 bacteriophage, the long tail fibres are involved in the recognition of bacterial surface receptors, while the short tail fibres bind irreversibly to the bacterial surface.
- Penetration- In T4 bacteriophage, changes in the structure of the baseplate trigger the contraction of the tail sheath. The tail apparatus penetrates the bacterial cell envelope with the help of the lysozyme domain of gp5 protein. The phage DNA enters the bacterial cytoplasm through the tail tube. The capsid remains outside the bacterial cell.
- Biosynthesis- The phage genes are expressed within the bacterial cell. The early genes mainly code for proteins involved in the regulation of host cell activities and replication of phage DNA. The late genes code for structural proteins of the bacteriophage and proteins involved in bacterial cell lysis. The amino acids, nucleotides, ribosomes and energy of the host cell are utilized for the production of phage components.
- Assembly and maturation- In T4 bacteriophage, the head, tail and long tail fibres are assembled separately. The newly synthesized phage DNA is packaged into the head with the help of an ATP-dependent enzyme complex called terminase. The DNA-containing head, tail and tail fibres join to form mature infectious bacteriophage particles.
- Lysis and release- The bacterial cell envelope is disrupted by phage-encoded proteins, resulting in the release of progeny bacteriophages. The number of infectious phages released from an infected bacterial cell is known as the burst size.
Mechanism of bacterial cell lysis
In many bacteriophages infecting Gram-negative bacteria, three types of proteins are involved in the lysis of the bacterial cell:
- Holins- These are small membrane proteins that accumulate in the cytoplasmic membrane of the bacterial cell. In lambda bacteriophage, the holin encoded by the S gene forms holes in the cytoplasmic membrane, through which the endolysin enters the periplasm.
- Endolysins- These are enzymes responsible for the degradation of peptidoglycan present in the bacterial cell wall. The endolysin of lambda bacteriophage is encoded by the R gene.
- Spanins- These proteins are involved in the disruption of the outer membrane of Gram-negative bacteria after degradation of the peptidoglycan layer. In lambda bacteriophage, the spanins are encoded by the Rz and Rz1 genes and bring about the fusion of the inner and outer membranes.

The degradation of peptidoglycan and disruption of the bacterial membranes result in the rupture of the bacterial cell and release of phage particles. Bacteriophages do not literally eat bacterial cells.
In some small DNA and RNA bacteriophages, bacterial cell lysis occurs due to the inhibition of enzymes involved in cell wall synthesis rather than the action of endolysins.
Lysogenic Cycle
The lysogenic cycle is found in temperate bacteriophages such as lambda (λ) bacteriophage. The phage genome remains within the bacterial cell as a prophage without causing immediate lysis of the host cell.

The different stages of the lysogenic cycle are mentioned below:
- Adsorption and penetration- Lambda bacteriophage binds to the LamB receptor present on the surface of Escherichia coli and introduces its double-stranded DNA into the bacterial cell. The linear phage DNA becomes circular by joining its complementary cohesive ends.
- Establishment of lysogeny- In lambda bacteriophage, the CII protein stimulates the production of the CI repressor. The CI repressor inhibits the expression of genes required for lytic infection.
- Prophage formation- The circular phage DNA is integrated into the bacterial chromosome by site-specific recombination with the help of an enzyme called integrase. In some other temperate bacteriophages, such as P1, the prophage remains outside the bacterial chromosome in the form of a plasmid.
- Replication of prophage- The integrated prophage DNA replicates along with the bacterial chromosome. During bacterial cell division, the prophage DNA is passed on to the daughter cells. A bacterial cell containing a prophage is known as a lysogen.
- Induction- DNA damage caused by factors such as ultraviolet radiation may lead to the induction of the prophage. In lambda bacteriophage, the bacterial RecA protein is activated during the SOS response and stimulates the self-cleavage of the CI repressor. The inhibition of lytic gene expression is removed.
- Lytic cycle- The prophage DNA is excised from the bacterial chromosome with the help of integrase and excisionase. Replication of phage DNA, synthesis of phage proteins and assembly of new bacteriophages take place, followed by lysis of the bacterial cell.
Chronic Infection Cycle
In chronic infection, the new bacteriophage particles are produced and released from the bacterial cell without causing immediate lysis of the host. This type of infection is found in filamentous bacteriophages such as M13.

- The pIII protein of M13 bacteriophage binds to the F pilus of the bacterial cell. The bacterial protein TolA acts as a secondary receptor.
- The single-stranded DNA of the bacteriophage enters the cytoplasm and is converted into a double-stranded DNA molecule known as the replicative form (RF) with the help of the host cellular machinery.
- The replicative form of DNA is used as a template for the synthesis of phage RNA and new copies of single-stranded DNA. The replication of phage DNA takes place by rolling-circle replication.
- The newly synthesized single-stranded DNA binds to the phage protein pV.
- During the extrusion of phage DNA through the bacterial cell envelope, the pV proteins are replaced by the major coat protein pVIII. The assembly and release of filamentous phage particles take place simultaneously.
- The infected bacterial cell remains viable and can continue to divide and produce new bacteriophage particles. However, the growth rate of the infected bacterial cell may decrease.
Differences Between Lytic, Lysogenic and Chronic Infection Cycles
| Characteristics | Lytic Cycle | Lysogenic Cycle | Chronic Infection Cycle |
|---|---|---|---|
| Fate of phage genome | Replicates within the host cell | Remains as a prophage | Replicates within the host cell |
| Integration into bacterial chromosome | Not required | May occur | Not required in M13 |
| Production of phage particles | Occurs during infection | Normally absent until induction | Continuous or prolonged |
| Lysis of bacterial cell | Occurs | Does not occur during lysogeny | Does not occur during normal phage release |
| Release of progeny phages | By bacterial cell lysis | Following induction into productive infection | By non-lytic extrusion in M13 |
| Bacterial cell division | ceases during productive lytic infection | Continues during lysogeny | May continue at a reduced rate |
| Examples | T4, T7 | Lambda (λ), P1 | M13, fd |
Examples of Bacteriophages
Some of the commonly studied bacteriophages are T2, T4, T7, lambda (λ), M13, P1, P22, φX174, MS2 and φ6.
- Bacteriophages T2, T4, T7 and lambda are some of the phages that infect Escherichia coli. Bacteriophages that infect E. coli are also known as coliphages.
- M13 and MS2 infect susceptible strains of E. coli possessing the F pilus.
- Some bacteriophages infect bacteria belonging to other genera. For example, P22 infects Salmonella, whereas φ6 infects Pseudomonas.
The different examples of bacteriophages, along with their hosts, characteristics and applications, are given below:
| Bacteriophage | Bacterial Host | Genetic Material | Morphology | Mode of Infection | Significance |
|---|---|---|---|---|---|
| T2 | Escherichia coli | Linear dsDNA | Head with a long contractile tail | Lytic | Used in the Hershey-Chase experiment to establish DNA as the genetic material. |
| T4 | Escherichia coli | Linear dsDNA | Elongated head with a contractile tail | Lytic | Used to study DNA replication, genetic recombination and phage assembly. |
| T7 | Escherichia coli | Linear dsDNA | Icosahedral head with a short non-contractile tail | Lytic | T7 RNA polymerase is used in recombinant gene expression systems. |
| Bacteriophage lambda (λ) | Escherichia coli | Linear dsDNA | Icosahedral head with a long non-contractile tail | Temperate | Used in gene cloning and in the study of gene regulation, lysogeny and specialized transduction. |
| M13 | F-positive Escherichia coli | Circular ssDNA | Filamentous | Chronic productive infection | Used in phage display and DNA sequencing. |
| P1 | Escherichia coli | Linear dsDNA | Head with a contractile tail | Temperate | Used in generalized transduction. |
| P22 | Salmonella enterica serovar Typhimurium | Linear dsDNA | Icosahedral head with a short non-contractile tail | Temperate | Used in the study of transduction and bacterial genetics. |
| φX174 | Escherichia coli | Circular ssDNA | Icosahedral, non-tailed | Lytic | It was the first DNA genome to be completely sequenced, in 1977. |
| MS2 | F-positive Escherichia coli | Linear positive-sense ssRNA | Icosahedral, non-tailed | Lytic | Its RNA genome was completely sequenced in 1976. It is also used in the study of RNA-protein interactions. |
| φ6 | Pseudomonas syringae pv. phaseolicola | Segmented dsRNA | Enveloped, non-tailed | Lytic | Used to study RNA virus replication, evolution and genetic reassortment. |
Distribution and Habitat of Bacteriophages
- Bacteriophages are found in aquatic as well as terrestrial environments.
- It is estimated that there are about 10³¹ bacteriophage particles on Earth, but their exact number is not known.
- The distribution of bacteriophages depends upon the distribution of their bacterial hosts. Their number in a particular habitat also depends upon the number and metabolic activity of susceptible bacteria present in that habitat.
- A millilitre of seawater collected from seas and oceans may contain about 10⁷ viral particles, most of which are bacteriophages.
- Bacteriophages are also found in freshwater bodies such as lakes, ponds and rivers. In India, bacteriophages have been isolated from rivers such as the Ganga (Ganges) and Yamuna. They are present in both polluted and relatively unpolluted river water.
- Sewage and wastewater contain large numbers of phages that infect different types of bacteria, including faecal bacteria such as Escherichia coli.
- Bacteriophages are found in soil, which may contain up to 10⁹ viral particles per gram.
- In marine as well as freshwater environments, the concentration of bacteriophages is often higher in the sediments than in the water above them.
- The bacteriophages associated with plants infect bacteria present on the surface of leaves, within the plant tissues and in the rhizosphere (soil surrounding the roots).
- In animals, bacteriophages are found in the gastrointestinal tract and other parts of the body inhabited by bacteria.
- Environmental factors such as temperature, pH, moisture, availability of nutrients and exposure to ultraviolet radiation influence the survival and multiplication of bacteriophages.
Functions of Bacteriophages

- Bacteriophages regulate the number of bacteria present in aquatic and terrestrial environments by causing lysis of susceptible bacterial cells.
- They help in maintaining bacterial diversity by reducing the population of dominant bacterial species or strains.
- Some bacteriophages transfer genetic material from one bacterial cell to another by transduction.
- The expression of certain genes present in a prophage results in changes in the characteristics of the bacterial host. This is known as lysogenic conversion.
- Bacteriophages are involved in the evolution of bacteria by selecting for phage-resistant bacterial variants. In turn, genetic variants of phages capable of infecting these resistant bacteria may be selected.
- The organic matter and nutrients released into the environment during the lysis of bacterial cells can be utilized by other microorganisms.
- Bacteriophages are involved in the cycling of carbon, nitrogen and phosphorus in nature.
- The presence of certain prophages within a bacterial cell protects it from infection by other related bacteriophages.
- The metabolic activities of the bacterial cell may be altered due to the expression of certain phage genes during infection.
Bacteriophages in Humans

- Bacteriophages are naturally present in the human body. They are found in large numbers in the gastrointestinal tract, particularly in the large intestine.
- They are also found in the oral cavity, on the surface of the skin and in some parts of the respiratory and urogenital tracts where bacteria are present.
- The viruses present in the human body are collectively known as the human virome. It includes bacteriophages as well as viruses that infect human cells. The population of bacteriophages present in the gastrointestinal tract is known as the gut phageome.
- Bacteriophages are found in the intestine both as free viral particles and as prophages within bacterial cells.
- They are involved in the regulation of the intestinal microbiota. The lysis of certain bacterial species by bacteriophages reduces their number in the intestine and may also influence the growth of other bacterial species.
- Genetic material can be transferred from one bacterial cell to another by bacteriophages through transduction. The genes acquired by bacteria may alter their metabolic activities, virulence and other characteristics.
- Some bacteriophages bind to the mucus covering the epithelial cells and may help in protecting these cells against certain bacterial pathogens.
- Bacteriophages cannot reproduce within human cells. However, some phages can enter human epithelial cells by endocytosis and pass through the epithelial layer by transcytosis without undergoing replication.
- Bacteriophages can interact with the cells of the human immune system and influence the production of cytokines. Antibodies specific to certain bacteriophages can also be produced in the human body.
- Changes in the composition and diversity of the gut phageome have been observed in individuals suffering from inflammatory bowel diseases (IBD), colorectal cancer and certain metabolic disorders. In many of these diseases, it is not yet known whether the changes in the phage population are a cause or a consequence of the disease.
Are Bacteriophages Harmful to Humans?
Bacteriophages are generally not harmful to humans because they infect bacterial cells and cannot reproduce within human cells. They are naturally present in different parts of the human body, particularly in the gastrointestinal tract.
However, some bacteriophages are indirectly responsible for diseases in humans. The genome of certain temperate bacteriophages contains genes coding for bacterial toxins. For example, the genes responsible for the production of cholera toxin in Vibrio cholerae and diphtheria toxin in Corynebacterium diphtheriae are carried by bacteriophages. Some phages are also involved in the transfer of genes associated with bacterial virulence and antibiotic resistance.
The administration of bacteriophages for the treatment of bacterial infections is known as phage therapy. Most clinical studies have reported that phage therapy is well tolerated. However, there are certain risks associated with its use:
- During the lysis of Gram-negative bacteria, endotoxins may be released, which can trigger an inflammatory response.
- Phage preparations contaminated with endotoxins and other bacterial components may cause adverse reactions.
- The administration of bacteriophages may stimulate the production of antibodies against them, which can reduce the effectiveness of phage therapy.
- Some bacteriophages may alter the composition of the normal bacterial microbiota.
- Fever and changes in liver enzyme levels have been reported in some patients receiving phage therapy, although their association with the administered phages is not always confirmed.
Virulent bacteriophages are generally preferred for phage therapy. Before administration, their genomes are examined for the presence of genes coding for toxins, antibiotic resistance and proteins involved in lysogeny. The phage preparations are purified to remove endotoxins and other bacterial contaminants.
Applications of Bacteriophages
The applications of bacteriophages are mentioned below:
- Treatment of certain bacterial infections by phage therapy, especially infections caused by antibiotic-resistant bacteria.
- Identification and differentiation of bacterial strains by phage typing.
- The presence of viable bacteria in clinical, food and environmental samples can be detected with the help of reporter bacteriophages.
- Lambda bacteriophage is used as a cloning vector in genetic engineering.
- P1 bacteriophage is used to transfer genes from one bacterial cell to another by generalized transduction.
- M13 bacteriophage is used in the production of single-stranded DNA for DNA sequencing.
- Selection of peptides and antibodies having affinity for specific molecules by phage display.
- T7 RNA polymerase is used for in vitro RNA synthesis and the production of recombinant proteins.
- In the food industry, bacteriophages are used to control foodborne pathogens such as Listeria monocytogenes, Salmonella and Escherichia coli.
- They are used as biological control agents against certain bacterial diseases in plants, e.g., fire blight in apples and pears.
- Studies are being carried out on the use of bacteriophages to control bacterial infections in poultry, livestock and aquatic animals.
- Certain bacteriophages and phage-derived enzymes can be used for the breakdown of bacterial biofilms.
- Coliphages are used as indicators of faecal contamination of water and to determine the efficiency of virus removal during water treatment.
- The use of bacteriophages to control the growth of undesirable bacteria in wastewater treatment plants is being studied.
- In molecular biology and genetics, bacteriophages are used to study DNA replication, genetic recombination, mutations and regulation of gene expression.
- Bacteriophages are also used in research related to the development of vaccines, drug delivery systems and identification of new therapeutic molecules.
Advantages of Bacteriophages
- Bacteriophages are highly host-specific and cause less damage to the normal bacterial microbiota as compared to broad-spectrum antibiotics.
- Lytic bacteriophages can kill both antibiotic-sensitive and antibiotic-resistant bacteria.
- They do not multiply within human cells.
- The number of bacteriophages may increase at the site of bacterial infection due to their multiplication within susceptible bacterial cells.
- Multiplication of bacteriophages ceases in the absence of suitable bacterial hosts.
- They can be used in combination with antibiotics to increase antibacterial activity in some cases.
- Certain bacteriophages produce enzymes that help in the degradation of bacterial biofilms.
- A mixture of different bacteriophages, known as a phage cocktail, can be used to increase the range of susceptible bacterial strains and reduce the chances of phage resistance.
- New bacteriophages can be isolated from natural sources such as soil, sewage and wastewater.
- Bacteriophages can be produced in large numbers with the help of suitable bacterial cultures at a relatively low cost.
- Phage preparations can be administered in different forms, such as liquids and creams, depending upon the site of infection.
Limitations of Bacteriophages
- Most bacteriophages have a narrow host range and can infect only certain species or strains of bacteria.
- In phage therapy, the identification of the disease-causing bacteria and testing of their susceptibility to bacteriophages may delay the treatment.
- Bacteria can develop resistance to bacteriophages due to changes in their surface receptors or the presence of various bacterial defence mechanisms.
- The multiplication of bacteriophages depends upon the number and metabolic activity of susceptible bacterial cells.
- Some bacteriophages cannot penetrate deep into bacterial biofilms.
- Bacteriophages may lose their infectivity when exposed to high temperatures, extreme pH and ultraviolet radiation.
- The acidic pH of the stomach may inactivate some of the orally administered bacteriophages.
- Antibodies produced against bacteriophages in the human body may neutralize them and reduce the effectiveness of phage therapy.
- The lysis of Gram-negative bacteria results in the release of endotoxins, which may induce an inflammatory response.
- Temperate bacteriophages may be involved in the transfer of genes responsible for toxin production, bacterial virulence and antibiotic resistance.
- It is difficult to maintain the stability and infectivity of some bacteriophage preparations for a prolonged period.
- The production of bacteriophages for clinical use requires purification, genetic screening and various quality control tests.
- There is limited data from controlled clinical trials regarding the effective dosage, duration of treatment and long-term safety of phage therapy.
- The regulatory requirements for the use of bacteriophages in medicine, agriculture and the food industry vary from one country to another.
References
- Barr, J. J., Auro, R., Furlan, M., Whiteson, K. L., Erb, M. L., Pogliano, J., Stotland, A., Wolkowicz, R., Cutting, A. S., Doran, K. S., Salamon, P., Youle, M., & Rohwer, F. (2013). Bacteriophage adhering to mucus provide a non-host-derived immunity. Proceedings of the National Academy of Sciences, 110(26), 10771–10776. https://doi.org/10.1073/pnas.1305923110
- Behera, B. K., Patra, B., Chakraborty, H. J., Rout, A. K., Dixit, S., Rai, A., Das, B. K., & Mohapatra, T. (2023). Bacteriophages diversity in India’s major river Ganga: A repository to regulate pathogenic bacteria in the aquatic environment. Environmental Science and Pollution Research, 30(12), 34101–34114. https://doi.org/10.1007/s11356-022-24637-7
- Brüssow, H., Canchaya, C., & Hardt, W.-D. (2004). Phages and the evolution of bacterial pathogens: From genomic rearrangements to lysogenic conversion. Microbiology and Molecular Biology Reviews, 68(3), 560–602. https://doi.org/10.1128/MMBR.68.3.560-602.2004
- Calendar, R., & Abedon, S. T. (Eds.). (2006). The bacteriophages (2nd ed.). Oxford University Press. https://doi.org/10.1093/oso/9780195148503.001.0001
- Clokie, M. R. J., Millard, A. D., Letarov, A. V., & Heaphy, S. (2011). Phages in nature. Bacteriophage, 1(1), 31–45. https://doi.org/10.4161/bact.1.1.14942
- D’Hérelle, F. (2007). On an invisible microbe antagonistic toward dysenteric bacilli: Brief note by Mr. F. D’Herelle, presented by Mr. Roux. 1917. Research in Microbiology, 158(7), 553–554. https://doi.org/10.1016/j.resmic.2007.07.005
- Hatfull, G. F., & Hendrix, R. W. (2011). Bacteriophages and their genomes. Current Opinion in Virology, 1(4), 298–303. https://doi.org/10.1016/j.coviro.2011.06.009
- Jofre, J., Lucena, F., Blanch, A. R., & Muniesa, M. (2016). Coliphages as model organisms in the characterization and management of water resources. Water, 8(5), Article 199. https://doi.org/10.3390/w8050199
- Jones, J. B., Jackson, L. E., Balogh, B., Obradovic, A., Iriarte, F. B., & Momol, M. T. (2007). Bacteriophages for plant disease control. Annual Review of Phytopathology, 45, 245–262. https://doi.org/10.1146/annurev.phyto.45.062806.094411
- Keen, E. C. (2015). A century of phage research: Bacteriophages and the shaping of modern biology. BioEssays, 37(1), 6–9. https://doi.org/10.1002/bies.201400152
- Kutter, E., & Sulakvelidze, A. (Eds.). (2005). Bacteriophages: Biology and applications. CRC Press. https://www.routledge.com/Bacteriophages-Biology-and-Applications/Sulakvelidze-Kutter/p/book/9780849313363
- Leiman, P. G., Kanamaru, S., Mesyanzhinov, V. V., Arisaka, F., & Rossmann, M. G. (2003). Structure and morphogenesis of bacteriophage T4. Cellular and Molecular Life Sciences, 60(11), 2356–2370. https://doi.org/10.1007/s00018-003-3072-1
- Liang, G., & Bushman, F. D. (2021). The human virome: Assembly, composition and host interactions. Nature Reviews Microbiology, 19(8), 514–527. https://doi.org/10.1038/s41579-021-00536-5
- Loc-Carrillo, C., & Abedon, S. T. (2011). Pros and cons of phage therapy. Bacteriophage, 1(2), 111–114. https://doi.org/10.4161/bact.1.2.14590
- Miller, E. S., Kutter, E., Mosig, G., Arisaka, F., Kunisawa, T., & Rüger, W. (2003). Bacteriophage T4 genome. Microbiology and Molecular Biology Reviews, 67(1), 86–156. https://doi.org/10.1128/MMBR.67.1.86-156.2003
- Moye, Z. D., Woolston, J., & Sulakvelidze, A. (2018). Bacteriophage applications for food production and processing. Viruses, 10(4), Article 205. https://doi.org/10.3390/v10040205
- Nguyen, S., Baker, K., Padman, B. S., Patwa, R., Dunstan, R. A., Weston, T. A., Schlosser, K., Bailey, B., Lithgow, T., Lazarou, M., Luque, A., Rohwer, F., Blumberg, R. S., & Barr, J. J. (2017). Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers. mBio, 8(6), Article e01874-17. https://doi.org/10.1128/mBio.01874-17
- Oppenheim, A. B., Kobiler, O., Stavans, J., Court, D. L., & Adhya, S. (2005). Switches in bacteriophage lambda development. Annual Review of Genetics, 39, 409–429. https://doi.org/10.1146/annurev.genet.39.073003.113656
- Rakonjac, J., Bennett, N. J., Spagnuolo, J., Gagic, D., & Russel, M. (2011). Filamentous bacteriophage: Biology, phage display and nanotechnology applications. Current Issues in Molecular Biology, 13(2), 51–76. https://doi.org/10.21775/cimb.013.051
- Salmond, G. P. C., & Fineran, P. C. (2015). A century of the phage: Past, present and future. Nature Reviews Microbiology, 13(12), 777–786. https://doi.org/10.1038/nrmicro3564
- Schofield, D. A., Sharp, N. J., & Westwater, C. (2012). Phage-based platforms for the clinical detection of human bacterial pathogens. Bacteriophage, 2(2), 105–121. https://doi.org/10.4161/bact.19274
- Shkoporov, A. N., & Hill, C. (2019). Bacteriophages of the human gut: The “known unknown” of the microbiome. Cell Host & Microbe, 25(2), 195–209. https://doi.org/10.1016/j.chom.2019.01.017
- Stacey, H. J., De Soir, S., & Jones, J. D. (2022). The safety and efficacy of phage therapy: A systematic review of clinical and safety trials. Antibiotics, 11(10), Article 1340. https://doi.org/10.3390/antibiotics11101340
- Suttle, C. A. (2007). Marine viruses—Major players in the global ecosystem. Nature Reviews Microbiology, 5(10), 801–812. https://doi.org/10.1038/nrmicro1750
- Toribio-Avedillo, D., Blanch, A. R., Muniesa, M., & Rodríguez-Rubio, L. (2021). Bacteriophages as fecal pollution indicators. Viruses, 13(6), Article 1089. https://doi.org/10.3390/v13061089
- Turner, D., Shkoporov, A. N., Lood, C., Millard, A. D., Dutilh, B. E., Alfenas-Zerbini, P., van Zyl, L. J., Aziz, R. K., Oksanen, H. M., Poranen, M. M., Kropinski, A. M., Barylski, J., Brister, J. R., Chanisvili, N., Edwards, R. A., Enault, F., Gillis, A., Knezevic, P., Krupovic, M., . . . Adriaenssens, E. M. (2023). Abolishment of morphology-based taxa and change to binomial species names: 2022 taxonomy update of the ICTV bacterial viruses subcommittee. Archives of Virology, 168(2), Article 74. https://doi.org/10.1007/s00705-022-05694-2
- Twort, F. W. (1915). An investigation on the nature of ultra-microscopic viruses. The Lancet, 186(4814), 1241–1243. https://doi.org/10.1016/S0140-6736(01)20383-3
- Uyttebroek, S., Chen, B., Onsea, J., Ruythooren, F., Debaveye, Y., Devolder, D., Spriet, I., Depypere, M., Wagemans, J., Lavigne, R., Pirnay, J.-P., Merabishvili, M., De Munter, P., Peetermans, W. E., Dupont, L., Van Gerven, L., & Metsemakers, W.-J. (2022). Safety and efficacy of phage therapy in difficult-to-treat infections: A systematic review. The Lancet Infectious Diseases, 22(8), e208–e220. https://doi.org/10.1016/S1473-3099(21)00612-5
- Varshney, A., & Sarethy, I. P. (2026). Metagenome-based insights into bacteriophage diversity of an urban river ecosystem. Molecular Biology Reports, 53(1), Article 561. https://doi.org/10.1007/s11033-026-11731-z
- Vikram, A., Woolston, J., & Sulakvelidze, A. (2021). Phage biocontrol applications in food production and processing. Current Issues in Molecular Biology, 40, 267–302. https://doi.org/10.21775/cimb.040.267
- Yap, M. L., & Rossmann, M. G. (2014). Structure and function of bacteriophage T4. Future Microbiology, 9(12), 1319–1327. https://doi.org/10.2217/fmb.14.91
- Young, R. (2014). Phage lysis: Three steps, three choices, one outcome. Journal of Microbiology, 52(3), 243–258. https://doi.org/10.1007/s12275-014-4087-z
Comments
Be the first to comment.